Minimed Group, Inc. MMED
NASDAQ
| 07/31/2026 | 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/25/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.21B | 3.09B | 2.97B | 2.87B | 2.79B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.21B | 3.09B | 2.97B | 2.87B | 2.79B |
| Cost of Revenue | 1.48B | 1.42B | 1.38B | 1.25B | 1.22B |
| Gross Profit | 1.73B | 1.67B | 1.60B | 1.62B | 1.57B |
| SG&A Expenses | 1.21B | 1.18B | 1.16B | 1.11B | 1.10B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 81.50M | 43.50M | 22.50M | -16.50M | -22.50M |
| Total Operating Expenses | 3.21B | 3.10B | 3.02B | 2.81B | 2.74B |
| Operating Income | -3.00M | -9.00M | -47.00M | 62.00M | 41.50M |
| Income Before Tax | -186.00M | -203.00M | -257.00M | -137.00M | -148.00M |
| Income Tax Expenses | 120.50M | 119.50M | 47.50M | 63.50M | 53.50M |
| Earnings from Continuing Operations | -306.50 | -322.50 | -304.50 | -200.50 | -201.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.00M | -15.00M | -20.00M | -15.00M | -15.00M |
| Net Income | -318.50M | -337.50M | -324.50M | -215.50M | -216.50M |
| EBIT | -3.00M | -9.00M | -47.00M | 62.00M | 41.50M |
| EBITDA | 155.00M | 147.00M | 108.00M | 215.00M | 189.50M |
| EPS Basic | -2.53 | -1.92 | -1.91 | -1.48 | -0.80 |
| Normalized Basic EPS | -0.07 | -0.09 | -0.20 | 0.09 | 0.09 |
| EPS Diluted | -2.54 | -1.92 | -1.91 | -1.48 | -0.80 |
| Normalized Diluted EPS | -0.07 | -0.09 | -0.20 | 0.09 | 0.09 |
| Average Basic Shares Outstanding | 801.91M | 773.71M | 758.37M | 758.37M | 758.37M |
| Average Diluted Shares Outstanding | 1.05B | 1.03B | 1.01B | 1.01B | 758.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -71.90% | -67.85% | -- | -- | -- |